PaxMedica announced that as a result of its 1-for-17 reverse stock split of its common stock that became effective at 8:03 a.m. Eastern Time on October 30, 2023, its common stock will begin trading on a split-adjusted basis with the open of the market on October 31, 2023. PaxMedica’s common stock will continue to trade under the existing trading symbol “PXMD.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on PXMD:
- PaxMedica Acquires Suramin Research Assets from Rediscovery Life Sciences to Accelerate NDA Submission for PAX-101
- PaxMedica Announces 1-for-17 Reverse Stock Split
- PaxMedica’s Research on Low Dose Suramin for Autism Spectrum Disorder Accepted for Publication
- PaxMedica says research on suramin for autism spectrum disorder to be published
- PaxMedica completes Type-B meeting with FDA for PAX-101 trial data